PRINTING COMPONENTS LIMITED
Company number 06993745 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: PRINTING COMPONENTS LIMITED
1. Financial Health Score: C+
Explanation: The patient presents a deceptively robust exterior—strong net assets of nearly £900k and a long trading history since 2009—but is suffering from a serious underlying condition: rapidly deteriorating cash reserves and apparent recurring losses. The heavy reliance on inter-company balances (£702,364) as a proportion of current assets masks what would otherwise be a critically thin liquidity position. Like a patient with good muscle mass but poor circulation, this business has substance but is experiencing significant constraints on its financial oxygen supply.
2. Key Vital Signs
💓 Cash Position — CRITICAL
| Year | Cash | Year-on-Year Change |
|---|---|---|
| 2021 | £505,771 | — |
| 2022 | £131,780 | -74% |
| 2023 | £232,718 | +77% |
| 2024 | £99,729 | -57% |
| 2025 | £56,183 | -44% |
Interpretation: This is the most alarming vital sign. Cash has plummeted by approximately 89% from its 2021 level. The most recent year saw cash nearly halve again. The cash-to-current-liabilities ratio stands at just 0.094—meaning the company has less than 10p for every £1 of short-term obligations. This is a patient struggling to breathe financially.
🩸 Working Capital — SUPERFICIALLY HEALTHY, INTERNALLY COMPROMISED
- Net Current Assets: £717,919 (appears strong)
- Current Ratio: 2.20 (appears healthy)
- Quick Ratio: 2.10 (appears healthy)
However, £702,364 (53% of current assets) represents amounts owed by group undertakings. If we exclude these inter-company balances—which may not be readily convertible to cash—the adjusted figures become:
- Adjusted Current Assets: £612,790
- Adjusted Current Ratio: 1.03
- Adjusted Net Current Assets: £15,555
This reveals the working capital is dangerously thin once the inter-company dependency is stripped away. Like relying on a family member to donate blood—it may work, but it's not a sustainable independent position.
🏥 Net Assets — STABLE BUT DECLINING
| Year | Net Assets | Change |
|---|---|---|
| 2022 | £660,748 | — |
| 2023 | £918,380 | +39% |
| 2024 | £924,372 | +0.7% |
| 2025 | £899,140 | -2.7% |
Net assets peaked in 2024 and have now declined. The P&L reserves dropped from £899,372 to £874,140—a reduction of £25,232, indicating the company made a loss in 2025.
📊 Liabilities — GROWING CONCERN
| Liability Category | 2024 | 2025 | Change |
|---|---|---|---|
| Current Liabilities | £554,876 | £597,235 | +7.6% |
| Long-term Liabilities | £37,837 | £99,499 | +163% |
| Provisions | £105,419 | £93,252 | -11.6% |
| Total | £698,132 | £789,986 | +13.2% |
Total liabilities have grown by 13.2% in a single year, with long-term creditors more than doubling. This represents a significant increase in the company's financial obligations.
🏭 Asset Composition — CAPITAL INTENSIVE WITH CONCENTRATION RISK
- Fixed Assets: £373,972 (22% of total assets)
- Intangible (development costs): £167,678
- Tangible (plant, fixtures, vehicles): £206,294
- Current Assets: £1,315,154 (78% of total assets)
- Inter-company receivables: £702,364 (53% of current assets)
- Trade debtors: £296,522
- Other debtors: £164,301
- Stock: £60,020
- Cash: £56,183
The concentration in inter-company receivables is a structural vulnerability. If the group structure experiences distress, this company's liquidity would collapse rapidly.
3. Diagnosis
Primary Conditions
1. Acute Cash Flow Deficiency The company is experiencing a severe cash haemorrhage. With only £56,183 in cash against £597,235 in current liabilities, the business has approximately 34 days of cash coverage (assuming current liabilities are spread evenly across the year). This is dangerously low for a manufacturing business that needs working capital for raw materials, payroll (18 employees), and operations.
2. Inter-Company Dependency Syndrome Over half of current assets are amounts owed by group undertakings. While this may reflect normal group treasury arrangements, it creates a single point of failure. The company's apparent liquidity is largely an illusion created by intra-group lending rather than genuine third-party receivables.
3. Profitability Deterioration The reduction in P&L reserves of £25,232 indicates the company traded at a loss in 2025. This follows a period of growth in net assets (likely from retained profits in earlier years), suggesting the business cycle has turned negative.
4. Rising Leverage Long-term liabilities jumped from £37,837 to £99,499—a 163% increase. Combined with rising current liabilities, the company is taking on more debt while generating losses. This is a concerning trajectory.
5. Asset Quality Concerns Development costs (£167,678) represent intangible assets being amortised at 25% annually. The significant amortisation charge of £108,857 in the year suggests either substantial prior capitalisation or accelerated write-offs. The recoverability of these development costs depends entirely on future revenue generation—which, given current losses, is uncertain.
Secondary Observations
- Trade Debtors of £296,522: Without turnover data, it's difficult to assess collection efficiency, but this represents a significant sum relative to cash balances.
- Stock Levels: £60,020—relatively modest, which is appropriate for a component manufacturer but may indicate constraints on purchasing ability.
- Hire Purchase Commitments: £47,982 in HP leases within current liabilities suggests ongoing asset financing requirements.
- Corporation Tax: £68,652 owed—this is a positive sign as it indicates the company was profitable in a prior period, but it's also a cash outflow that will need to be funded.
4. Prognosis
Short-term Outlook (6-12 months): CAUTIOUS
The immediate concern is whether the company can meet its obligations as they fall due. With only £56,183 in cash and £597,235 in current liabilities, the business is heavily reliant on: - Collecting trade debts promptly - Inter-company settlements from group undertakings - Generating positive cash flow from operations
If any of these fail, the company could face a liquidity crisis.
Medium-term Outlook (1-3 years): GUARDED
The trajectory is concerning. The combination of: - Declining cash reserves - Rising liabilities - Apparent operating losses - Heavy inter-company dependence
...suggests the business is in a period of financial stress. However, the strong net asset base (£899,140) provides a buffer against insolvency, and the group structure may provide support through the inter-company arrangements.
Key Risk: Contagion from Group
As a subsidiary of PCL UK Holdings Limited (which owns >75% of shares), the company's fortunes are tied to the group. If the parent or fellow group companies experience distress, the £702,364 inter-company balance could become impaired, and the company's apparent working capital would evaporate.
5. Recommendations
🚨 Immediate Actions (0-3 months)
-
Cash Flow Stabilisation: Implement a 13-week rolling cash flow forecast to identify and manage short-term liquidity gaps. This is the financial equivalent of putting the patient on a heart monitor.
-
Inter-Company Balance Review: Negotiate clear repayment terms for the £702,364 owed by group undertakings. Establish whether this is a permanent feature of group treasury or a temporary balance that should be settling.
-
Trade Debtor Collection: Focus management attention on collecting the £296,522 in trade debtors. Even a modest improvement in days sales outstanding could significantly improve cash position.
-
Creditor Management: With £118,775 in trade creditors, ensure critical suppliers are paid on time to maintain supply relationships, while negotiating extended terms where possible.
💊 Medium-term Treatments (3-12 months)
-
Profitability Recovery: Conduct a detailed review of the loss-making operations. The shift from profit to loss requires identification of the root causes—whether pricing pressure, cost inflation, or volume decline.
-
Capital Expenditure Review: The company invested £111,500 in plant and equipment in 2025 while making a loss. Evaluate whether this investment is generating adequate returns and whether further capex should be deferred.
-
Development Costs Assessment: With £167,678 in capitalised development costs and £108,857 in amortisation, review whether these intangible assets will generate future economic benefits. If not, an impairment charge may be necessary to present a true picture.
-
Long-term Liability Management: The jump in long-term creditors from £37,837 to £99,499 needs investigation. Understand the terms, interest rates, and repayment schedules of these obligations.
🏋️ Long-term Health Improvements (12+ months)
-
Diversify Revenue Streams: Reduce dependency on group arrangements by developing third-party revenue channels that generate independent cash flow.
-
Working Capital Optimisation: Implement formal working capital management policies covering inventory, debtor days, and creditor terms.
-
Financial Buffer Rebuilding: Target a minimum cash reserve equivalent to 3 months of operating costs to provide resilience against future shocks.
Risk Factors to Monitor
| Indicator | Current Status | Warning Threshold | Action Required |
|---|---|---|---|
| Cash Balance | £56,183 | Below £30,000 | Immediate cash flow intervention |
| Current Ratio (excl. inter-company) | 1.03 | Below 1.0 | Working capital injection |
| Inter-company Balance | £702,364 | Any increase | Review group treasury policy |
| P&L Reserves Trend | Declining | Two consecutive loss years | Strategic review |
| Long-term Liabilities | £99,499 | Any significant increase | Debt serviceability assessment |